Literature DB >> 29524791

Polybacterial stimulation suggests discrete IL-6/IL-6R signaling in human fetal membranes: Potential implications on IL-6 bioactivity.

Nathalia Mayumi Noda-Nicolau1, Jossimara Polettini2, Márcia Guimarães da Silva3, Morgan R Peltier4, Ramkumar Menon5.   

Abstract

The polybacterial invasion of the amniotic cavity and risk of preterm birth is often due to cervicovaginal bacteria such as genital mycoplasmas (Mycoplasma hominis and Ureaplasma urealyticum) and Gardnerella vaginalis. The most studied biomarker associated with preterm birth is interleukin-6 (IL-6), a pleiotropic cytokine that performs different functions based on classical or trans-signaling mechanisms. This study evaluated the changes in IL-6 and IL-6 function associated accessory molecules by human fetal membranes to determine the functional availability of IL-6 assessment in an in vitro model of polybacterial infection. Fetal membranes were treated with LPS or heat-inactivated genital mycoplasmas and G. vaginalis alone or in combination. IL-6 and its soluble receptors (sgp130, sIL-6R) were assessed in conditioned medium by immunoassays and membrane-bound receptors were evaluated in the tissue using immunohistochemistry and RT-PCR. Data from protein and gene expression were evaluated using linear mixed effects models. Data from immunohistochemistry were evaluated using one-way analysis of variance followed by the Tukey test. Genital mycoplasmas alone, or in combination, inhibited IL-6 trans-signaling with increased sgp130 production. G. vaginalis activated the classical IL-6 signaling pathway, as did LPS. Polybacterial treatment resulted in a balanced response with neither pathway being favored. The increase in IL-6 production by fetal membranes in response to infection is likely a non-specific innate response and not an indicator of a functional mediator of any labor-inducing pathways. This suggests that correlating the risk of adverse pregnancy outcomes and designing interventions based on IL-6 levels without considering soluble receptors may be an ineffective strategy.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fetal membranes in vitro; Genital mycoplasmas; Interleukin-6; Polybacterial infection

Mesh:

Substances:

Year:  2018        PMID: 29524791     DOI: 10.1016/j.jri.2018.02.007

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  7 in total

1.  Inflammatory response elicited by Ureaplasma parvum colonization in human cervical epithelial, stromal, and immune cells.

Authors:  Ourlad Alzeus G Tantengco; Talar Kechichian; Kathleen L Vincent; Richard B Pyles; Paul Mark B Medina; Ramkumar Menon
Journal:  Reproduction       Date:  2021-12-09       Impact factor: 3.906

2.  Modeling ascending Ureaplasma parvum infection through the female reproductive tract using vagina-cervix-decidua-organ-on-a-chip and feto-maternal interface-organ-on-a-chip.

Authors:  Ourlad Alzeus G Tantengco; Lauren S Richardson; Enkhtuya Radnaa; Ananth Kumar Kammala; Sungjin Kim; Paul Mark B Medina; Arum Han; Ramkumar Menon
Journal:  FASEB J       Date:  2022-10       Impact factor: 5.834

Review 3.  Genital Mycoplasmas and Biomarkers of Inflammation and Their Association With Spontaneous Preterm Birth and Preterm Prelabor Rupture of Membranes: A Systematic Review and Meta-Analysis.

Authors:  Nathalia M Noda-Nicolau; Ourlad Alzeus G Tantengco; Jossimara Polettini; Mariana C Silva; Giovana F C Bento; Geovanna C Cursino; Camila Marconi; Ronald F Lamont; Brandie D Taylor; Márcia G Silva; Daniel Jupiter; Ramkumar Menon
Journal:  Front Microbiol       Date:  2022-03-30       Impact factor: 5.640

4.  Exosomes from Ureaplasma parvum-infected ectocervical epithelial cells promote feto-maternal interface inflammation but are insufficient to cause preterm delivery.

Authors:  Ourlad Alzeus G Tantengco; Lauren S Richardson; Enkhtuya Radnaa; Ananth Kumar Kammala; Sungjin Kim; Paul Mark B Medina; Arum Han; Ramkumar Menon
Journal:  Front Cell Dev Biol       Date:  2022-08-15

5.  Interleukin (IL)-6: A Friend or Foe of Pregnancy and Parturition? Evidence From Functional Studies in Fetal Membrane Cells.

Authors:  Chasey Omere; Lauren Richardson; George R Saade; Elizabeth A Bonney; Talar Kechichian; Ramkumar Menon
Journal:  Front Physiol       Date:  2020-07-24       Impact factor: 4.566

Review 6.  A Comprehensive Review of Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome.

Authors:  Sajad Khiali; Elnaz Khani; Taher Entezari-Maleki
Journal:  J Clin Pharmacol       Date:  2020-07-27       Impact factor: 2.860

Review 7.  Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

Authors:  Bingwen Liu; Min Li; Zhiguang Zhou; Xuan Guan; Yufei Xiang
Journal:  J Autoimmun       Date:  2020-04-10       Impact factor: 7.094

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.